Check out our earnings calendar for this week, as well as our previews and recaps of the more noteworthy reports.

Arrowhead Pharmaceuticals strikes a $130M+ deal with Sanofi for plozasiran in Greater China, targeting high triglyceride ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) is a biotechnology company specializing in RNA interference (RNAi) therapeutics ...

On Monday, Chiefs Kingdom received a new update from owner Clark Hunt, who described the situation as having "two great ...

Two separate AI-generated images were edited together to create what appeared to be an "incredibly rare" solar halo over ...

There are plenty of high-quality undervalued stocks to buy right now, you just need to know where to look. Here, we highlight ...

Stock of Sarepta Therapeutics Inc. (NASDAQ: SRPT) surged 38.89% in Tuesday pre-market following the U.S. Food and Drug ...

Chiefs owner and CEO Clark Hunt said Monday the team has not made a final decision on its future stadium, but added there is some “urgency” for a decision.

FDA probes Elevidys after an 8-year-old's death in Brazil; Sarepta and Roche say the death was unrelated to gene therapy ...

Arrowhead Pharmaceuticals (ARWR) stock gains as company reassures investors about financial obligations required from Sarepta ...

Sarepta Therapeutics' licensing partner Arrowhead Pharmaceuticals said on Wednesday it expects to receive near-term milestone ...

Stock Market News From July 17, 2025: S&P 500, Nasdaq Notch Record Highs The Dow also rose after retail sales and jobless claims data came in better than expected.